Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma

Phil S. Chung, Chung K. Rhee, Kwang H. Kim, Woo Paek, Juliet Chung, Marcos B. Paiva, Adrien Eshraghi, Dan J. Castro, Romaine E. Saxton

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objectives/Hypothesis: To test intratumoral photodynamic therapy (IPDT) as a new treatment for squamous cell carcinoma in a preclinical tumor model. Study Design and Methods: Human P3 squamous carcinoma cells were transplanted subcutaneously in athymic nude mice and allowed to grow into 300- to 500-mm3 tumors. Hypericin dye at 1 μg/gm of body weight was injected intratumorally (IT) or intravenously (IV). After 4 hours hypericin biodistribution was assessed in ethanol extracts from tissues by fluorescence spectroscopy. IPDT also was tested by KTP laser fiberoptic insertion in tumors 4 hours after IT dye injection compared to KTP532 laser therapy alone (532 nm, 1W, 40-60 J, 0.6-mm fiber). Results: Hypericin concentration tissues was as follows: (IT vs. IV) for tumors (3660 vs. 135 ng dye/gm tissue), lung (760 vs. 6345), liver (75 vs. 935), blood (65 vs. 480) compared to skin (465 vs. 110) or muscle (335 vs. 80) adjacent to the squamous cell tumors. Four hours after dye injection, the tumor exhibited bright orange fluorescence when excited by KTP 532-nm green laser light. The IPDT-treated tumors had a 3.32 ± 0.32-mm radius of cell destruction when H and E-stained sections were examined compared with 2.5 ± 0.38 mm for the laser only control group (n = 10, P = .003). Conclusions: This pilot study indicates laser IPDT with hypericin induces a significant increase in tumor necrosis compared with laser alone and may be useful as a less invasive adjuvant treatment for recurrent or inoperable human squamous cell cancers of the head and neck.

Original languageEnglish
Pages (from-to)1312-1316
Number of pages5
JournalLaryngoscope
Volume110
Issue number8
StatePublished - Aug 29 2000
Externally publishedYes

Fingerprint

Solid-State Lasers
Laser Therapy
Squamous Cell Carcinoma
Photochemotherapy
Neoplasms
Lasers
Coloring Agents
Nude Mice
Methyl Green
Squamous Cell Neoplasms
Injections
Tissue Extracts
hypericin
Fluorescence Spectrometry
Head and Neck Neoplasms
Ethanol
Necrosis
Fluorescence
Epithelial Cells
Body Weight

Keywords

  • Hypericin
  • Interstitial laser fiberoptics
  • Phototherapy
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Chung, P. S., Rhee, C. K., Kim, K. H., Paek, W., Chung, J., Paiva, M. B., ... Saxton, R. E. (2000). Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. Laryngoscope, 110(8), 1312-1316.

Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. / Chung, Phil S.; Rhee, Chung K.; Kim, Kwang H.; Paek, Woo; Chung, Juliet; Paiva, Marcos B.; Eshraghi, Adrien; Castro, Dan J.; Saxton, Romaine E.

In: Laryngoscope, Vol. 110, No. 8, 29.08.2000, p. 1312-1316.

Research output: Contribution to journalArticle

Chung, PS, Rhee, CK, Kim, KH, Paek, W, Chung, J, Paiva, MB, Eshraghi, A, Castro, DJ & Saxton, RE 2000, 'Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma', Laryngoscope, vol. 110, no. 8, pp. 1312-1316.
Chung PS, Rhee CK, Kim KH, Paek W, Chung J, Paiva MB et al. Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. Laryngoscope. 2000 Aug 29;110(8):1312-1316.
Chung, Phil S. ; Rhee, Chung K. ; Kim, Kwang H. ; Paek, Woo ; Chung, Juliet ; Paiva, Marcos B. ; Eshraghi, Adrien ; Castro, Dan J. ; Saxton, Romaine E. / Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. In: Laryngoscope. 2000 ; Vol. 110, No. 8. pp. 1312-1316.
@article{135d70e1cc8648bc9dbbc8b1aff2a272,
title = "Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma",
abstract = "Objectives/Hypothesis: To test intratumoral photodynamic therapy (IPDT) as a new treatment for squamous cell carcinoma in a preclinical tumor model. Study Design and Methods: Human P3 squamous carcinoma cells were transplanted subcutaneously in athymic nude mice and allowed to grow into 300- to 500-mm3 tumors. Hypericin dye at 1 μg/gm of body weight was injected intratumorally (IT) or intravenously (IV). After 4 hours hypericin biodistribution was assessed in ethanol extracts from tissues by fluorescence spectroscopy. IPDT also was tested by KTP laser fiberoptic insertion in tumors 4 hours after IT dye injection compared to KTP532 laser therapy alone (532 nm, 1W, 40-60 J, 0.6-mm fiber). Results: Hypericin concentration tissues was as follows: (IT vs. IV) for tumors (3660 vs. 135 ng dye/gm tissue), lung (760 vs. 6345), liver (75 vs. 935), blood (65 vs. 480) compared to skin (465 vs. 110) or muscle (335 vs. 80) adjacent to the squamous cell tumors. Four hours after dye injection, the tumor exhibited bright orange fluorescence when excited by KTP 532-nm green laser light. The IPDT-treated tumors had a 3.32 ± 0.32-mm radius of cell destruction when H and E-stained sections were examined compared with 2.5 ± 0.38 mm for the laser only control group (n = 10, P = .003). Conclusions: This pilot study indicates laser IPDT with hypericin induces a significant increase in tumor necrosis compared with laser alone and may be useful as a less invasive adjuvant treatment for recurrent or inoperable human squamous cell cancers of the head and neck.",
keywords = "Hypericin, Interstitial laser fiberoptics, Phototherapy, Squamous cell carcinoma",
author = "Chung, {Phil S.} and Rhee, {Chung K.} and Kim, {Kwang H.} and Woo Paek and Juliet Chung and Paiva, {Marcos B.} and Adrien Eshraghi and Castro, {Dan J.} and Saxton, {Romaine E.}",
year = "2000",
month = "8",
day = "29",
language = "English",
volume = "110",
pages = "1312--1316",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma

AU - Chung, Phil S.

AU - Rhee, Chung K.

AU - Kim, Kwang H.

AU - Paek, Woo

AU - Chung, Juliet

AU - Paiva, Marcos B.

AU - Eshraghi, Adrien

AU - Castro, Dan J.

AU - Saxton, Romaine E.

PY - 2000/8/29

Y1 - 2000/8/29

N2 - Objectives/Hypothesis: To test intratumoral photodynamic therapy (IPDT) as a new treatment for squamous cell carcinoma in a preclinical tumor model. Study Design and Methods: Human P3 squamous carcinoma cells were transplanted subcutaneously in athymic nude mice and allowed to grow into 300- to 500-mm3 tumors. Hypericin dye at 1 μg/gm of body weight was injected intratumorally (IT) or intravenously (IV). After 4 hours hypericin biodistribution was assessed in ethanol extracts from tissues by fluorescence spectroscopy. IPDT also was tested by KTP laser fiberoptic insertion in tumors 4 hours after IT dye injection compared to KTP532 laser therapy alone (532 nm, 1W, 40-60 J, 0.6-mm fiber). Results: Hypericin concentration tissues was as follows: (IT vs. IV) for tumors (3660 vs. 135 ng dye/gm tissue), lung (760 vs. 6345), liver (75 vs. 935), blood (65 vs. 480) compared to skin (465 vs. 110) or muscle (335 vs. 80) adjacent to the squamous cell tumors. Four hours after dye injection, the tumor exhibited bright orange fluorescence when excited by KTP 532-nm green laser light. The IPDT-treated tumors had a 3.32 ± 0.32-mm radius of cell destruction when H and E-stained sections were examined compared with 2.5 ± 0.38 mm for the laser only control group (n = 10, P = .003). Conclusions: This pilot study indicates laser IPDT with hypericin induces a significant increase in tumor necrosis compared with laser alone and may be useful as a less invasive adjuvant treatment for recurrent or inoperable human squamous cell cancers of the head and neck.

AB - Objectives/Hypothesis: To test intratumoral photodynamic therapy (IPDT) as a new treatment for squamous cell carcinoma in a preclinical tumor model. Study Design and Methods: Human P3 squamous carcinoma cells were transplanted subcutaneously in athymic nude mice and allowed to grow into 300- to 500-mm3 tumors. Hypericin dye at 1 μg/gm of body weight was injected intratumorally (IT) or intravenously (IV). After 4 hours hypericin biodistribution was assessed in ethanol extracts from tissues by fluorescence spectroscopy. IPDT also was tested by KTP laser fiberoptic insertion in tumors 4 hours after IT dye injection compared to KTP532 laser therapy alone (532 nm, 1W, 40-60 J, 0.6-mm fiber). Results: Hypericin concentration tissues was as follows: (IT vs. IV) for tumors (3660 vs. 135 ng dye/gm tissue), lung (760 vs. 6345), liver (75 vs. 935), blood (65 vs. 480) compared to skin (465 vs. 110) or muscle (335 vs. 80) adjacent to the squamous cell tumors. Four hours after dye injection, the tumor exhibited bright orange fluorescence when excited by KTP 532-nm green laser light. The IPDT-treated tumors had a 3.32 ± 0.32-mm radius of cell destruction when H and E-stained sections were examined compared with 2.5 ± 0.38 mm for the laser only control group (n = 10, P = .003). Conclusions: This pilot study indicates laser IPDT with hypericin induces a significant increase in tumor necrosis compared with laser alone and may be useful as a less invasive adjuvant treatment for recurrent or inoperable human squamous cell cancers of the head and neck.

KW - Hypericin

KW - Interstitial laser fiberoptics

KW - Phototherapy

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0033884250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033884250&partnerID=8YFLogxK

M3 - Article

C2 - 10942132

AN - SCOPUS:0033884250

VL - 110

SP - 1312

EP - 1316

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 8

ER -